Foundation Fighting Blindness and Institut de recherche pour le développement are funding Opus Genetics' work on gene therapies targeting pathogenic variants in the Mer gene.
1 report, 0 independent
Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Foundation Fighting Blindness and Institut de recherche pour le développement are funding Opus Genetics' work on gene therapies targeting pathogenic variants in the Mer gene.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Mer
Norwegian operator of charging stations
Nothing else this week.
-
Foundation Fighting Blindness
organization
-
French National Research Institute for Sustainable Development
French science and technology research institute
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet